Inventiva reports preliminary financial results for Full-Year 2022¹
February 14, 2023 16:00 ET
|
INVENTIVA
Daix (France), Long Island City (New York, United States), February 14, 2023 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...
Infant Bacterial Therapeutics AB (publ) Bokslutskommuniké 1 januari – 31 december 2022
February 10, 2023 02:00 ET
|
Infant Bacterial Therapeutics AB
VD kommenterar Under de sista tre månaderna av 2022 var rekryteringen av prematura spädbarn till vår omfattande fas 3 studie betydligt bättre än vad den var under motsvarande period de föregående...
Infant Bacterial Therapeutics AB (publ) Interim report January 1- December 31, 2022
February 10, 2023 02:00 ET
|
Infant Bacterial Therapeutics AB
Message from the CEO The speed of recruitment of preterm infants into our large phase 3 study significantly increased in the final three months of 2022 compared to the corresponding period in...
Infant Bacterial Therapeutics publicerar Årsredovisning för 2021 i XHTML format
January 27, 2023 08:55 ET
|
Infant Bacterial Therapeutics AB
Den 31 mars 2022 publicerade IBT sin årsredovsning för 2021. Filformatet som då användes var PDF. Idag publicerar IBT samma rapport i XHTML format. Innehållet i rapporten har inte ändrats. se...
Infant Bacterial Therapeutics publishes Annual Report for 2021 in XHTML format
January 27, 2023 08:55 ET
|
Infant Bacterial Therapeutics AB
On March 31 2022 IBT published the 2021 annual report in the format of a PDF file. Today, IBT publish the same report in the XHTML format. The content of the report has not been changed. see...
Interim Financial Report Third quarter ended 30 September 2022
November 30, 2022 02:30 ET
|
Jøtul AS
YTD Q3 2022, the Jotul Group reached a consolidated profit of MNOK 4.5 (YTD Q3 2021: loss of MNOK 57.5). The operating profit totaled MNOK 95.5 in YTD Q3 2022 (YTD Q3 2021: MNOK 12.9). The 2022 total...
Castellum, Inc. Announces Strong Third Quarter Financial Results Including Record Revenue
November 15, 2022 06:55 ET
|
Castellum, Inc.
BETHESDA, Md., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, data analytics, software, and IT services company focused...
Inventiva publie ses informations financières du 3ème trimestre 2022¹
November 10, 2022 16:00 ET
|
INVENTIVA
Position de trésorerie2 à 72,6 M€ au 30 septembre 2021 , sans prise en compte du paiement de 12,6 M$ reçu le 4 novembre de la part de Sino BiopharmChiffre d’affaires de 0,1 M€ sur les neuf premiers...
Inventiva reports 2022 Third Quarter Financial Information¹
November 10, 2022 16:00 ET
|
INVENTIVA
Cash position2 at €72.6m as of September 30, 2022, not including the $12.6 million upfront payment received from Sino Biopharm on November 4, 2022Revenues of €0.1m for the first nine months of 2022 ...
Infant Bacterial Therapeutics AB (publ) (IBT), delårsrapport 1 juli – 30 september 2022
November 10, 2022 02:00 ET
|
Infant Bacterial Therapeutics AB
VD kommenterar Vårt utvecklingsprojekt IBP-9414 i klinisk fas III fortskrider väl, och som jag tidigare nämnt arbetar vi med flera aktiviteter för att påskynda genomförandet av vår studie. Det är...